Patent · US Active

Treatment and prevention of malaria

US9884101B2 · kind B2 · utility

1Cited by
1References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 30, 2015
Grant dateFeb 6, 2018
Priority date
Expiry dateJul 30, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to recombinant fragments of Plasmodium polypeptides and polynucleotides encoding same. The invention further relates to compositions comprising the recombinant fragments of Plasmodium polypeptides and their use in the treatment and prevention of malaria.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.